Page last updated: 2024-11-04

kojic amine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Kojic amine is a synthetic derivative of kojic acid, a natural fungal metabolite. It is characterized by its potent tyrosinase inhibitory activity, making it a promising ingredient for skin lightening and anti-melanogenesis applications. Kojic amine's mechanism of action involves the chelation of copper ions, which are essential cofactors for tyrosinase, the enzyme responsible for melanin production. Research has demonstrated its effectiveness in reducing hyperpigmentation, melasma, and post-inflammatory hyperpigmentation. However, there are concerns regarding its potential for skin irritation and sensitization, and further studies are needed to fully understand its safety profile. The interest in kojic amine stems from its ability to address the growing demand for skin lightening products, particularly in Asian and African markets. Despite its potential, the development of kojic amine-based formulations requires careful consideration of its efficacy, safety, and stability.'

kojic amine: author refers to above as GABA analog; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3841
CHEMBL ID3246269
SCHEMBL ID3571439
MeSH IDM0071065

Synonyms (14)

Synonym
kojic amine
2-aminomethyl-5-hydroxy-pyran-4-one
2-(aminomethyl)-5-hydroxy-4h-pyran-4-one
68642-64-8
2-(aminomethyl)-5-hydroxypyran-4-one
AKOS006282159
4h-pyran-4-one, 2-(aminomethyl)-5-hydroxy-
FT-0608724
AULIQBZSRZXJJU-UHFFFAOYSA-N
CHEMBL3246269
SCHEMBL3571439
DTXSID50218734
aminokojicacid
EN300-77265

Research Excerpts

Effects

ExcerptReferenceRelevance
"Kojic amine (3) has been found to possess certain of the properties to be expected in a gamma-aminobutyric acid mimetic agent, notably skeletal muscle relaxant activity."( Kojic amine--a novel gamma-aminobutyric acid analogue.
Atkinson, JG; Girard, Y; McFarlane, CS; Rackham, A; Rokach, J; Rooney, CS; Share, NN, 1979
)
2.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1137323Skeletal muscle relaxant activity in po dosed chronic spinal mongrel cat assessed as reduction of flexor spasm administered every 15 mins interval1979Journal of medicinal chemistry, Jan, Volume: 22, Issue:1
Kojic amine--a novel gamma-aminobutyric acid analogue.
AID1137326Dissociation constant, pKa of the compound1979Journal of medicinal chemistry, Jan, Volume: 22, Issue:1
Kojic amine--a novel gamma-aminobutyric acid analogue.
AID1137324Toxicity in Swiss mouse at 128 mg/kg, po1979Journal of medicinal chemistry, Jan, Volume: 22, Issue:1
Kojic amine--a novel gamma-aminobutyric acid analogue.
AID1137319Skeletal muscle relaxant activity in iv dosed chronic spinal Sprague-Dawley rat assessed as reduction of flexor spasm administered every 15 mins interval1979Journal of medicinal chemistry, Jan, Volume: 22, Issue:1
Kojic amine--a novel gamma-aminobutyric acid analogue.
AID1137321Skeletal muscle relaxant activity in iv dosed chronic spinal mongrel cat assessed as reduction of flexor spasm administered every 15 mins interval1979Journal of medicinal chemistry, Jan, Volume: 22, Issue:1
Kojic amine--a novel gamma-aminobutyric acid analogue.
AID1137318Anticonvulsant activity in po dosed Swiss mouse assessed as reduction of 3-mercaptopropionic acid-induced tonic extensor-seizures within 3 to 7 mins1979Journal of medicinal chemistry, Jan, Volume: 22, Issue:1
Kojic amine--a novel gamma-aminobutyric acid analogue.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (90.91)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.57 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]